<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2812223046
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2022
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        Demsone 10 mg per 5 ml 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DEXAMETHASONE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Oral solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        150
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        17
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        392.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Rosemont Pharmaceuticals Ltd" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Rosemont Pharmaceuticals Ltd
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 653]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            YAHMAA MEDICAL COMPANY
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Rosemont Pharmaceuticals Ltd
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        H02AB02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The full name of your medicine is Demsone 10mg/5ml Oral Solution. It contains dexamethasone sodium phosphate. This belongs to a group of medicines called Corticosteroids.<br />Corticosteroids are hormones that are found naturally in your body that help to keep you healthy and well. Boosting your body with extra corticosteroid, such as Demsone, is an effective way to treat various illnesses involving inflammation in the body. Demsone lowers inflammation, which could otherwise go on making your condition worse. You must take this medicine regularly to get maximum benefit from it.<br />Demsone can be used in adults for:<br />&bull; replacing natural corticosteroids when levels have been reduced<br />&bull; treating swelling (inflammation) and certain allergies<br />&bull; reducing swelling of the brain which is not caused by a head injury<br />&bull; treating cancer<br />&bull; controlling how well your adrenal glands work. These are glands that are next to your kidneys<br />&bull; treating a number of different diseases of the immune system.<br />You may be using this medicine for a different reason. Ask your doctor why this medicine has been prescribed for you.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Demsone:<br />&bull; if you are allergic to Dexamethasone or any of the other ingredients of this medicine (listed in section 6). The signs of an allergic reaction include a rash, itching or shortness of breath<br />&bull; if you have an infection (including fungal infections) that affects the whole body, unless you are being treated for the infection<br />&bull; if you have an infection with tropical worms<br />&bull; if you need to have a vaccination with a &lsquo;live virus&rsquo; vaccine<br />&bull; if you have an ulcer in your stomach (peptic ulcer) or digestive tract area (duodenal ulcer)<br />&bull; to treat a serious lung disease called Acute Respiratory Distress Syndrome if you have had this problem for more than 2 weeks.<br />Do not take this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Demsone.<br />Mental health problems<br />Check with your doctor first:<br />&bull; if you have ever had severe depression or manic depression (bipolar disorder). This includes having had depression before while taking steroid medicines like Demsone<br />&bull; if any of your close family has had these illnesses.<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.3.2<br />Package Leaflet<br />Version: January 2022 Page 3<br />If either of these applies to you, talk to your doctor before taking this medicine.<br />Mental health problems can happen while taking steroids like Demsone (see also section 4: Possible side effects).<br />&bull; These illnesses can be serious.<br />&bull; Usually they start within a few days or weeks of starting the medicine.<br />&bull; They are more likely to happen at high doses.<br />&bull; Most of these problems go away if the dose is lowered or the medicine is stopped. However, if problems do happen, they might need treatment.<br />Talk to a doctor if you (or someone taking this medicine), show any signs of mental problems. This is particularly important if you are depressed or might be thinking about suicide. In a few cases, mental problems have happened when doses were being lowered or stopped.<br />Warnings and precautions<br />Talk to your doctor or pharmacist before taking Demsone if you have:<br />&bull; kidney or liver problems<br />&bull; high blood pressure, heart disease or you have recently had a heart attack<br />&bull; diabetes or there is a family history of diabetes<br />&bull; thinning of the bones (osteoporosis), particularly if you are a female who has been through the menopause<br />&bull; had muscle weakness with dexamethasone or other steroids in the past<br />&bull; you have myasthenia gravis. The signs of this may be long term tiredness (fatigue) and muscle weakness<br />&bull; raised eye pressure (glaucoma) or there is a family history of glaucoma<br />&bull; a stomach (peptic) ulcer<br />&bull; mental problems or you have had a mental illness which was made worse by this type of medicine such as &ldquo;steroid psychosis&rdquo;<br />&bull; epilepsy<br />&bull; migraines<br />&bull; had an allergy or unusual reaction to corticosteroids<br />&bull; an underactive thyroid gland<br />&bull; an infection with parasites<br />&bull; TB (tuberculosis), septicaemia or a fungal infection in the eye<br />&bull; malaria that affects the brain (cerebral malaria)<br />&bull; herpes, including cold sores or genital herpes<br />&bull; asthma<br />&bull; stunted growth<br />&bull; a cancer of the blood because you may be at risk of a very rare, potentially life-threatening condition resulting from a sudden breakdown of tumour cells<br />&bull; symptoms of tumour lysis syndrome such as muscle cramping, muscle weakness, confusion, visual loss or disturbances and shortness of breath, in case you suffer from haematological malignancy.<br />Contact your doctor if you experience blurred vision or other visual disturbances.<br />If any of the above apply to you (or you are not sure), talk to your doctor or pharmacist before taking Demsone.<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.3.2<br />Package Leaflet<br />Version: January 2022 Page 4<br />Taking a steroid medicine like Demsone<br />Please tell your doctor, or anyone giving you treatment, that you are taking or have recently taken Demsone, if any of the following things happen to you. This is because your dose of Dexamethasone may need to be increased during this time:<br />&bull; you get ill or develop an infection<br />&bull; you have an accident or other injury<br />&bull; you need to have any surgery, including dental work<br />&bull; you need to have a &lsquo;live virus&rsquo; vaccine such as MMR, tuberculosis (TB), yellow fever or oral typhoid.<br />Chickenpox, shingles and measles:<br />While you are taking this kind of medicine, you should not come into contact with anyone who has chickenpox, shingles or measles if you have not had these illnesses. This is because you may need specialist treatment if you get these diseases. If you think you may have had exposure to any of these diseases, you should talk to your doctor immediately. You should also tell your doctor if you have ever had infectious diseases such as measles or chickenpox and if you have had any vaccinations for these conditions in the past.<br />Children and young people<br />This strength of dexamethasone is not recommended for use in children and young people. However if a child is taking this medicine at a doctors request, it is important that the doctor monitors their growth and development regularly. Dexamethasone should not be routinely given to premature babies with respiratory problems.<br />Older people<br />Some of the side effects of Dexamethasone may be more serious in older people. Your doctor may need to monitor you more closely for the following:<br />&bull; diabetes<br />&bull; getting infections<br />&bull; thinning of the skin<br />&bull; high blood pressure<br />&bull; thinning of the bones (osteoporosis)<br />&bull; low potassium levels in the blood (hypokalaemia).<br />Other medicines and Demsone<br />Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines you buy without a prescription, including herbal medicines. This is because Demsone can affect the way some other medicines work. Also, some medicines can affect the way Demsone works.<br />Some medicines may increase the effects of Demsone and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat).<br />In particular, tell your doctor if you are taking any of the following:<br />&bull; medicines to treat heart and blood problems, such as warfarin, high blood pressure medicines, such as captopril or verapamil, a cholesterol lowering medicine called colestyramine and water tablets (diuretics)<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.3.2<br />Package Leaflet<br />Version: January 2022 Page 5<br />&bull; medicines to treat infections, such as amphotericin B iv injection, rifabutin, rifampicin, a medicine for fungal infections called ketoconazole, antibiotics including erythromycin, a medicine for worm infections called praziquantel and a medicine for tuberculosis called isoniazid<br />&bull; medicines to treat viral infections such as indinavir and saquinavir<br />&bull; live vaccines such as MMR, tuberculosis, yellow fever or oral typhoid<br />&bull; medicines to treat epilepsy, such as phenytoin, carbamazepine, primidone, phenobarbital and acetazolamide, also used for glaucoma<br />&bull; medicines to treat stomach problems, such as antacids, charcoal and carbenoxolone. You should leave at least two hours between taking these medicines and Demsone<br />&bull; medicines that calm emotions or for sleeping, such as barbiturates or sulpiride<br />&bull; medicines that control pain or lower inflammation, such as aspirin or similar non-steroidal anti-inflammatory drugs (NSAIDs), such as indometacin, hydrocortisone, cortisone and other corticosteroids. You should be carefully monitored if you are taking NSAIDs at the same time as taking Demsone because you are more likely to get stomach or gut ulcers<br />&bull; medicines used to treat diabetes such as insulin, metformin or sulfonylureas such as chlorpropamide<br />&bull; medicines used to lower potassium levels<br />&bull; medicines that help muscle movement in myasthenia gravis, such as neostigmine<br />&bull; ritonavir, indinavir or saquinavir used to treat HIV<br />&bull; oestrogen and progestogen including the contraceptive pill<br />&bull; ciclosporin used to stop the rejection of organs after transplants<br />&bull; anti-cancer treatments, such as aminoglutethimide and thalidomide, also used for leprosy<br />&bull; ephedrine which helps to tighten blood vessels<br />&bull; tetracosactide<br />&bull; methotrexate used for cancer or inflammatory problems.<br />If you are not sure if any of the above apply to you, talk to your doctor or pharmacist before taking Demsone.<br />Pregnancy and breast-feeding<br />Talk to your doctor before taking this medicine if you are pregnant, planning<br />to become pregnant or are breast-feeding.<br />There is not enough information on the use of dexamethasone during pregnancy to know the possible side effects. For this reason, the use of Demsone during pregnancy is not recommended unless advised to by your doctor.<br />Dexamethasone is excreted in breast milk. It may influence the growth of your baby or cause other side effects. Tell your doctor if you are or intend to breast-feed before taking Demsone.<br />Driving and using machines<br />You may experience dizziness when taking this medicine (see section 4: Possible side effects). This may affect your ability to drive. If this happens, do not drive or use tools or machinery.<br />Demsone contains sorbitol and maltitol<br />This medicine contains sorbitol and maltitol. If your doctor has told you that you cannot tolerate some sugars, see your doctor before taking this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.<br />How to take<br />&bull; This medicine contains 10mg of dexamethasone in each 5ml. Each 1ml contains 2mg of dexamethasone.<br />&bull; Take this medicine by mouth.<br />&bull; For oral administration, always use the oral syringe supplied with the pack.<br />&bull; You may also find that your doctor will tell you to lower the amount of salt in your diet.<br />&bull; You may also find that your doctor asks you to take potassium supplements whilst taking this medicine. If so, they will monitor you more closely.<br />Measuring your dose using the oral syringe provided:<br />1. Open the bottle: press the cap and turn it anticlockwise (figure 1).<br />2. Insert the syringe adaptor into the bottle neck (figure 2).<br />3. Take the syringe and put it in the adaptor opening (figure 2).<br />4. Turn the bottle upside down (figure 3).<br />5. Fill the syringe with a small amount of solution by pulling the piston down (figure 4A). Then push the piston upward in order to remove any possible bubbles (figure 4B). Finally, pull the piston down to the graduation mark corresponding to the quantity in millilitres (ml) prescribed by your doctor (figure 4C).<br />6. Turn the bottle the right way up.<br />7. Remove the syringe from the adaptor. Put the end of the syringe into your mouth and push the piston slowly back in to take the medicine.<br />8. Wash the syringe with water and let it dry before you use it again.<br />9. Close the bottle with the plastic screw cap.<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.3.2<br />Package Leaflet<br />Version: January 2022 Page 7<br />This medicine can also be administered via nasogastric (NG) or percutaneous endoscopic gastrostomy (PEG) tubes only. There is further information in the SmPC, ask your doctor, pharmacist or nurse for this information.<br />Taking this medicine via NG or PEG tubes<br />1. Ensure the tube is clear before taking the medicine.<br />2. Flush the tube with water, a minimum flush volume of 5mL of water is required.<br />3. Administer the medicine into the tube with a suitable measuring device. The syringe included in the pack is only for patients who are able to swallow the medicine. Healthcare Professional (HCPs) administering this product to patients via a NG or PEG tube must use another suitable device.<br />4. Flush the tube with water again using a minimum volume of 5mL of water.<br />For use with silicone, PVC and polyurethane NG or PEG tubes only.<br />The usual dose for adults and older people<br />&bull; Take 0.5mg (0.25ml) to 10mg (5ml) each day.<br />&bull; This total daily dose can be split into two or three smaller doses to be taken throughout the day.<br />&bull; Your doctor will decide your exact dose based on how serious your illness is.<br />&bull; As you get better your doctor may then reduce your dose or ask you to take another steroid medicine, such as prednisolone.<br />If you are taking this medicine as part of hospital tests:<br />&bull; Take 0.5mg (0.25ml) to 2mg (1ml) for each dose.<br />&bull; You will have this medicine for a short period of time.<br />If you take more Demsone than you should<br />If you take more of this medicine than you should, talk to a doctor or go to a hospital straight away. Take the medicine pack with you so the doctor knows what you have taken.<br />If you forget to take Demsone<br />&bull; If you forget a dose, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose.<br />&bull; Do not take a double dose (two doses at the same time) to make up for a forgotten dose.<br />If you stop taking Demsone<br />&bull; It can be dangerous to stop taking this medicine suddenly. If you need to stop this treatment, follow your doctor&rsquo;s advice. He or she may tell you to lower the amount of medicine you are taking gradually until you stop taking it altogether. This will allow your adrenal glands to recover to their normal function.<br />&bull; If you stop taking this medicine too quickly, you may have low blood pressure and, in some cases, your illness could come back.<br />&bull; You may also feel a &lsquo;withdrawal symptom&rsquo;. This may include fever, pain in your muscles and joints, swelling in the inside of your nose, weight loss, itchy skin and conjunctivitis.<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.3.2<br />Package Leaflet<br />Version: January 2022 Page 8<br />If you have any further questions on the use of this medicine, ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.<br />Serious side effects: tell a doctor straight away<br />Steroids including Dexamethasone can cause serious mental health problems. These are common in both adults and children. They can affect about 5 in every 100 people taking medicines like Dexamethasone. These include:<br />&bull; feeling depressed, including thinking about suicide<br />&bull; feeling high (mania), very happy (euphoria) or moods that go up and down<br />&bull; feeling anxious or irritable, having problems sleeping, difficulty in thinking or being confused and losing your memory<br />&bull; feeling, seeing or hearing things that do not exist or believing in things that are not real (delusions). Having strange and frightening thoughts, changing how you act or having feelings of being alone<br />&bull; schizophrenia becoming worse.<br />If you notice any of these problems, talk to a doctor straight away.<br />If you have an allergic reaction to Demsone, stop taking it and seek medical help immediately.<br />An allergic reaction may include:<br />&bull; any kind of skin rash, flaking skin, boils or sore lips and mouth<br />&bull; sudden wheezing, fluttering or tightness of the chest or collapse.<br />If you get any of the following side effects, stop taking Demsone and see your doctor as soon as possible:<br />&bull; stomach and gut problems: inflamed food pipe (oesophagus), ulcers in the food pipe or gut that may split and bleed, feeling sick (nausea) or being sick (vomiting), stomach ache or a swollen stomach, having more of an appetite than usual, hiccups, diarrhoea, tearing of the bowel, particularly if you have inflammatory bowel disease<br />&bull; inflamed pancreas: this may cause severe pain in the back or tummy<br />&bull; problems with salts in your blood: such as too much sodium or low potassium or calcium. You may have water retention<br />&bull; heart and blood problems: heart failure in people who are likely to have heart problems, high blood pressure, blood clots (signs of this may include redness, pain or numbness, throbbing, a burning feeling or swelling). There could also be a large rise in the number of white cells in your body. Some types of blood tests will show this affecting you<br />&bull; bone problems: thinning of the bones with more of a risk of fractures, also hip, arm and leg bone problems, ruptured tendons, muscle wasting and muscle weakness<br />&bull; recurring infections that get worse each time. This may be a sign that your immune system is low. Recurrence of TB (tuberculosis) if you have already had it before. You may also get thrush<br />&bull; skin problems: wounds that heal more slowly, thinned, delicate skin, unusual purple spots on the skin or bruising, redness and inflammation of the skin, weaker reaction to<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.3.2<br />Package Leaflet<br />Version: January 2022 Page 9<br />skin tests, stretch marks, acne, sweating more than usual, skin rash or swollen small veins under the skin, thinning of hair &bull; eye problems: cataracts, increased pressure in the eye including glaucoma swelling inside the eye, blurred vision, thinning of the covering of the eyeball, eye infections that you may already have can become worse, bulging of the eyeballs. Frequency rare: blurred vision. Frequency not known: visual disturbances, loss of vision<br />&bull; hormone problems: growth of extra body hair (particularly in women), weight gain, irregular or missing periods, changes in the levels of protein and calcium in your body (which would be detected by a blood test), stunted growth in children and teenagers and swelling and weight gain of the body and face (called &lsquo;Cushingoid state&#39;)<br />Dexamethasone may affect your diabetes and you may notice you start needing higher doses of the medicine you take for diabetes. While taking Dexamethasone your body may not be able to respond normally to severe stress such as accidents, surgery or illness<br />&bull; nervous system problems: fits or epilepsy may become worse, feeling<br />dizzy, headache, severe unusual headache with visual problems usually<br />in children (normally after treatment has been stopped), a feeling that you<br />are addicted to the medicine, being unable to sleep, feeling depressed,<br />extreme mood swings<br />&bull; other side effects: may make you feel generally unwell. If you are a man, this medicine can affect the amount of sperm and their movement.<br />Reporting of side effects<br />If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.<br />You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.<br />The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the sight and reach of children.<br />&bull; Do not use after the expiry date which is stated on the label and carton (Exp: month, year). The expiry date refers to the last day of that month.<br />&bull; Do not store above 25&deg;C. Do not refrigerate or freeze. Store in the original package in order to protect from light.<br />&bull; Use within 1 month of opening.<br />&bull; Do not use Demsone if you can see solid particles inside the solution or notice anything wrong with the medicine. Talk to your pharmacist.<br />&bull; Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Demsone contains<br />&bull; The active ingredient is Dexamethasone Sodium Phosphate. This medicine contains 10mg of Dexamethasone (as sodium phosphate) in each 5ml of solution. Each 1ml contains 2mg of Dexamethasone (as sodium phosphate).<br />&bull; The other ingredients are propylene glycol (E1520), benzoic acid (E210), citric acid monohydrate (E330), sodium citrate (E331), liquid maltitol (E965), sorbitol liquid (non crystallising) (E420) and purified water.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Dexamethasone Oral Solution looks like and contents of the pack
• Your medicine is a colourless to faint yellow oral solution.
• It comes in a brown glass bottle holding 30ml or 150ml of solution with a 5ml purple syringe and adaptor. Not all pack sizes may be marketed
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Rosemont Pharmaceuticals Ltd, Yorkdale Industrial Park, Braithwaite Street, Leeds, LS11 9XE, UK.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in 01/2022
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>معلومات مھمة عن ھذا الدواء<br />&bull; دیمزون ھو دواء ستیرویدي ، یتم وصفھ للعدید من الحالات المختلفة ، بما في ذلك الأمراض الشدیدة .<br />&bull; تحتاج إلى تناولھ بانتظام للحصول على أقصى فائدة .<br />&bull; لا تتوقف عن تناول ھذا الدواء دون التحدث إلى طبیبك - فقد تحتاج إلى تقلیل الجرعة تدریجیاً .<br />&bull; یمكن أن یسبب دیمزون تأثیرات جانبیة لدى بعض الأشخاص )اقرأ القسم :4 الآثار الجانبیة المحتملة( . یمكن أن تحدث بعض<br />المشاكل مثل تغیرات المزاج )الشعور بالاكتئاب ، أو &quot; النشاط&quot;( ، أو مشاكل في المعدة على الفور . إذا كنت تشعر بتوعك ، بأي حال<br />من الأحوال ، استمر بتناول الدواء ، لكن استشر طبیبك على الفور<br />&bull; بعض الآثار الجانبیة تحدث فقط بعد أسابیع أو أشھر . وتشمل ھذه الآثار ضعف الذراعین والساقین ، أو حدوث وجھ مستدیر<br />)اقرأ القسم 4 لمزید من المعلومات .(<br />&bull; الابتعاد عن الأشخاص الذین لدیھم جدري الماء أو القوباء المنطقیة ، إذا لم تكن قد أصبت بھم . یمكن أن تؤثر علیك بشدة . إذا كنت في<br />تلامس مع جدري الماء أو القوباء المنطقیة ، فاستشر طبیبك على الفور .<br />الآن اقرأ بقیة النشرة . فھي تتضمن معلومات ھامة أخرى حول الاستخدام الآمن والفعال لھذا الدواء الذي قد یكون مھ مًا بشكل خاص<br />بالنسبة لك .<br />تم تحدیث ھذه النشرة في 01 / 2022<br />&bull; اقرأ كل ھذه النشرة بعنایة قبل البدء في تناول ھذا الدواء .<br />&bull; احتفظ بھذه النشرة . قد تحتاج لقراءتھا مرة أخرى .<br />&bull; إذا كانت لدیك أي أسئلة أخرى ، فاسأل طبیبك أو الصیدلي .<br />&bull; تم وصف ھذا الدواء لك فقط . لا تنقلھ للأخرین . قد یؤذیھم ، حتى لو كانت أعراضھم مماثلة لأعراضك .<br />&bull; إذا كان أي من ھذه الآثار الجانبیة خطیر ا ، أو إذا لاحظت أي آثار جانبیة غیر مدرجة في ھذه النشرة ، یرجى إخبار طبیبك أو<br />الصیدلي .<br />في ھذه النشرة :<br />.1 ما ھو دیمزون لماذا یستخدم<br />.2 ما تحتاج إلى معرفتھ قبل أن تأخذ دیمزون<br />.3 كیف تأخذ دیمزون<br />4 . الآثار الجانبیة المحتملة<br />.5 كیفیة تخزین دیمزون<br />.6 مزید من المعلومات<br />.1 ما ھو ديمزون ولماذا يستخدم<br />اسم الدواء الخاص بك ھو دیمزون ، وھو یحتوي على دكسامیثازون فوسفات الصودیوم . وھو ینتمي إلى مجموعة من الأدویة تسمى<br />الستیرویدات القشریة . الستیرویدات القشریة ھي ھرمونات موجودة بشكل طبیعي في الجسم تساعد على الحفاظ على صحتك جیدة . إن<br />تعزیز جسمك باستخدام ستیروید قشري إضافي ، مثل دیمزون ، ھو طریقة فعالة لعلاج الأمراض المختلفة التي تنطوي على التھاب<br />في الجسم . دیمزون یخفض الالتھاب ، الذي یمكن أن یستمر في جعل حالتك أسوأ . یجب تناول ھذا الدواء بانتظام للحصول على<br />أقصى فائدة منھ .<br />یمكن استخدام دیمزون في :<br />&bull; تعویض الستیرویدات القشریة الطبیعیة عند انخفاض مستویاتھا<br />&bull; علاج التورم )التھاب( وبعض أنواع الحساسیة.<br />&bull; الحد من تورم المخ الغیر ناتج عن إصابة في الرأس<br />&bull; علاج السرطان<br />&bull; التحكم في جودة عمل الغدد الكظریة . ھذه ھي الغدد المجاورة لكلیتك<br />&bull; علاج العدید من الأمراض المختلفة للجھاز المناعي .<br />قد تستخدم ھذا الدواء لسبب مختلف . اسأل طبیبك لماذا تم وصف ھذا الدواء لك .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>لا تأخذ دیمزون إذا :<br />&bull; لدیك حساسیة إلى دكسامیثازون أو أي مكونات أخرى في ھذا الدواء ) المدرجة في القسم (6<br />تشمل علامات التفاعلات التحسسیة طفح جلدي ، حكة أو ضیق في التنفس<br />&bull; لدیك التھاب ) بما في ذلك الالتھابات الفطریة ( التي تؤثر على الجسم كلھ ، إلا إذا كنت تتعالج من الالتھاب<br />&bull; لدیك التھاب ناتج عن الدیدان الاستوائیة .<br />&bull; كنت بحاجة لأخذ لقاح یحتوي على فیروس مضعّف.<br />&bull; لدیك قرحة في المعدة ) قرحة ھضمیة ( أو منطقة الجھاز الھضمي )قرحة الاثني عشر ( .<br />&bull; كان لمعالجة مرض رئوي خطیر یدعى متلازمة الضائقة التنفسیة الحادة، في حال استمرت ھذه المتلازمة لمدة أكثر من أسبوعین .<br />لا تأخذ ھذا الدواء إذا كان أي مما سبق ینطبق علیك ، تحدث مع طبیبك أو الصیدلي قبل أخذ دیمزون .<br />المشاكل الصحیة العقلیة<br />تحقق مع طبیبك اولا :<br />&bull; إذا كنت تعاني من اكتئاب حاد أو اكتئاب ھوسي ) اضطراب ثنائي القطب .( وھذا یشمل وجود الاكتئاب قبل تناول أدویة الستیروید<br />مثل دكسامیثازون .<br />&bull; إذا كان أي من أفراد عائلتك القریبة مصاباً بھذه الأمراض .<br />إذا كان أي من ھذین ینطبق علیك ، تحدث إلى الطبیب قبل تناول ھذا الدواء .<br />یمكن أن تحدث مشاكل الصحة العقلیة أثناء تناول الستیرویدات مثل دیمزون ) انظر أیضا القسم :4 الآثار الجانبیة المحتملة .(<br />&bull; یمكن أن تكون ھذه الأمراض خطیرة<br />&bull; عادة ما تبدأ في غضون بضعة أیام أو أسابیع من بدء الدواء<br />&bull; من المرجح أن تحدث بجرعات عالیة<br />&bull; تزول معظم ھذه المشكلات إذا تم خفض الجرعة أو توقف الدواء . ومع ذلك ، إذا حدثت مشاكل ، فقد یحتاجون إلى العلاج .<br />تحدث إلى الطبیب إذا كنت )أو أي شخص یتناول ھذا الدواء ( ، أظھر أي علامات على وجود مشاكل عقلیة . ھذا مھم بشكل خاص إذا<br />كنت تعاني من الاكتئاب ، أو ربما تفكر في الانتحار . في حالات قلیلة ، حدثت مشاكل عقلیة عندما تم تخفیض الجرعات أو إیقافھا .<br />المحاذير والإحتیاطات<br />تحدث إلى طبیبك أو الصیدلي قبل تناول دیمزون إذا كان لدیك :<br />&bull; مشاكل في الكلى أو الكبد.<br />&bull; ارتفاع ضغط الدم أو أمراض القلب أو كنت قد تعرضت مؤخرا لنوبة قلبیة.<br />&bull; مرض السكري أو ھناك تاریخ عائلي لمرض السكري.<br />&bull; ترقق العظام ) ھشاشة العظام ( ، لا سیما إذا كنتي أنثى من خلال انقطاع الطمث.<br />&bull; كان یعاني من ضعف العضلات مع ھذا الستیروید أو غیره من الستیرویدات في الماضي.<br />&bull; الوھن العضلي الشدید، وقد تكون من علاماتھ الإرھاق طویل الأمد وضعف العضلات.<br />&bull; رفع ضغط العین ) الجلوكوما ( أو وجود تاریخ عائلي من الجلوكوما<br />&bull; قرحة في المعدة<br />&bull; مشاكل عقلیة أو إذا كنت قد تعرضت لمرض عقلي وكان أسوأ بسبب ھذا النوع من الدواء<br />&bull; الصرع<br />&bull; الصداع النصفي<br />&bull; حساسیة أو رد فعل غیر عادي للستیرویدات القشریة<br />&bull; الغدة الدرقیة غیر النشطة<br />&bull; عدوى بالطفیلیات<br />&bull; السل أو انتان الدم أو عدوى فطریة في العین<br />&bull; الملاریا التي تصیب الدماغ ) الملاریا الدماغیة (<br />&bull; الھربس ، بما في ذلك القروح الباردة أو الھربس التناسلي<br />&bull; الربو<br />&bull; تقزم النمو<br />&bull; سرطان الدم لأنك قد تكون معرضا لخطر الاصابة بحالة نادرة جداً مھددة للحیاة نتیجة الانھیار المفاجئ لخلایا الدم.<br />&bull; أعراض متلازمة تحلل الورم مثل التشنج العضلي ، وضعف العضلات ، الارتباك ، فقدان البصر أو الاضطرابات البصریة وضیق<br />التنفس ، في حال كنت تعاني من ورم دموي خبیث .<br />Dexamethasone 10 mg/ 5 ml Oral<br />Solution<br />Module 1.3.3.2<br />Leaflet<br />Version: January 2022 Page 12<br />اتصل بطبیبك إذا كنت تعاني من عدم وضوح الرؤیة أو اضطرابات بصریة أخرى .<br />إذا لم تكن متأكدا مما إذا كان أي مما سبق ینطبق علیك ، تحدث إلى طبیبك أو الصیدلي قبل استخدام دیمزون .<br />أخذ دواء الستیرويد مثل ديمزون<br />یرجى إخبار طبیبك ، أو أي شخص یعطیك العلاج ، أنك تتناول أو تناولت دیمزون مؤخر اً ، إذا حدث لك أي من الأشیاء التالیة، لأن<br />جرعتك من دیكسامیثازون قد تحتاج إلى زیادة خلال ھذا الوقت :<br />- تعرضت للمرض أو تم اصابتك بعدوى .<br />- تعرضت لحادث أو إصابة أخرى .<br />- أنت بحاجة إلى أي عملیة جراحیة ، بما في ذلك جراحة الأسنان .<br />- أنت بحاجة إلى لقاح &quot;فیروس حي&quot; مثل لقاح الحصبة-النكاف-الحصبة الألمانیة MMR ، السل ) TB ( ، الحمى الصفراء أو التیفوئید<br />الفموي.<br />جدري الماء والقوباء المنطقیة والحصبة :<br />أثناء تناولك ھذا النوع من الأدویة ، یجب ألا تتلامس مع أي شخص مصاب بجدري الماء أو القوباء المنطقیة أو الحصبة . ھذا لأنك قد<br />تحتاج إلى علاج متخصص إذا أصبت بھذه الأمراض . إذا كنت تعتقد أنك قد تعرضت لأي من ھذه الأمراض ، یجب علیك التحدث مع<br />طبیبك على الفور . یجب علیك أیضا إخبار طبیبك إذا كنت تعاني من أي أمراض معدیة مثل الحصبة أو جدري الماء ، وإذا كنت قد<br />تلقیت أي تطعیمات لھذه الحالات في الماضي .<br />الأطفال وصغار السن<br />ھذا التركیز من دكسامیثازون لا ینصح بھ للأطفال وصغار السن.<br />إذا أخذ الطفل ھذا الدواء بناء على طلب الطبیب ، فمن المھم أن یراقب الطبیب نموه وتطوره بانتظام . لا ینبغي إعطاء دكسامیثازون<br />بشكل روتیني للأطفال الخدج الذین یعانون من مشاكل في الجھاز التنفسي.<br />كبار السن<br />قد تكون بعض التأثیرات الجانبیة لدكسامیثازون أكثر خطورة في كبار السن. وقد یحتاج طبیبك لمراقبة حالتك في الحالات التالیة:<br />- مرض السكري<br />- الاصابة بالإلتھابات<br />- ترقق الجلد<br />- ضغط الدم المرتفع<br />- ترقق العظام<br />- انخفاض مستویات البوتاسیوم في الدم.<br />الأدوية الاخرى و ديمزون<br />أخبر طبیبك أو الصیدلي إذا كنت تأخذ ، أو أخذت مؤخرا أو قد تأخذ أي أدویة أخرى . وھذا یشمل الأدویة التي تشتریھا دون وصفة<br />طبیة ، بما في ذلك الأدویة العشبیة . وذلك لأن دیمزون یمكن أن یؤثر على طریقة عمل بعض الأدویة الأخرى . أیضا ، یمكن<br />لبعض الأدویة أن تؤثر على الطریقة التي یعمل بھا دیمزون.<br />قد تزید بعض الأدویة من تأثیرات دیمزون وقد یرغب طبیبك في مراقبتك بعنایة إذا كنت تتناول ھذه الأدویة )بما في ذلك بعض<br />الأدویة الخاصة بفیروس نقص المناعة البشریة : ریتونافیر، كوبیسستات(.<br />على وجھ الخصوص ، أخبر طبیبك إذا كنت تأخذ أیا مما یلي :<br /> أدویة لعلاج مشاكل القلب والدم ، مثل الوارفارین ، أدویة ضغط الدم المرتفع مثل كابتوبریل أو فیرابامیل ، دواء خفض<br />الكولیسترول المسمى كولستیرامین وأقراص المدرات البولیة .<br />&bull; أدویة لعلاج الالتھابات ، مثل حقن الأمفوتیرسین ب، ریفامبیوتین، ریفامبسین، دواء للعدوى الفطریة یسمى كیتوكونازول،<br />المضادات الحیویة بما في ذلك الاریثرومایسین ، دواء للإلتھابات الناتجة عن الدیدان یدعى برازیكوانتیل ودواء لمرض السل یسمى<br />أیسونیازید .<br /> أدویة لعلاج الالتھابات الفیروسیة مثل إندینافیر، سكوینافیر<br /> اللقاحات الحیة مثل اللقاح الثلاثي أو السل أو الحمى الصفراء أو التیفوئید الفموي .<br />&bull; أدویة لعلاج الصرع ، مثل فینیتوین ، كاربامازبین ، بریمیدون ، فینوباربیتال وأسیتازولامید ، وتستخدم أیضا للجلوكوما<br />&bull; أدویة لعلاج مشاكل المعدة ، مثل مضادات الحموضة والفحم والكاربینوكسولون . یجب علیك ترك ساعتین على الأقل بین تناول ھذه<br />الأدویة و دیمزون.<br />&bull; الأدویة التي تھدئ العواطف أو للنوم ، مثل الباربیتورات أو السلبیرید .<br />&bull; الأدویة التي تتحكم في الألم أو تقلل الالتھاب ، مثل الأسبرین أو مضادات الالتھاب غیر الستیرویدیة ، مثل إندومیثاسین<br />Dexamethasone 10 mg/ 5 ml Oral<br />Solution<br />Module 1.3.3.2<br />Leaflet<br />Version: January 2022 Page 13<br />وھیدروكورتیزون وكورتیزون والستیرویدات القشریة الأخرى . یجب أن تتم مراقبتك بعنایة إذا كنت تتناول مضادات الالتھاب غیر<br />الستیرویدیة في نفس الوقت الذي تتناول فیھ دیمزون لأنك أكثر عرضة للإصابة بالقرحة المعدیة أو المعویة .<br /> الأدویة المستخدمة لعلاج مرض السكري مثل الأنسولین ، میتفورمین أو سلفونیل یوریا مثل كلوربروبامید.<br /> الأدویة المستخدمة لتخفیض مستویات البوتاسیوم بالدم.<br />&bull; الأدویة التي تساعد على حركة العضلات في الوھن العضلي الوبیل ، مثل نیوستیجمین.<br />&bull; ریتونافیر ، المستخدم لعلاج فیروس نقص المناعة البشریة.<br />&bull; أقراص ھرمون الاستروجین والبروجسترون بما في ذلك حبوب منع الحمل.<br />&bull; سیكلوسبورین الذي یستخدم لوقف رفض الأعضاء بعد عملیات الزرع.<br />&bull; العلاجات المضادة للسرطان ، مثل أمینوغلوتیثیمید وثالیدوماید ، والتي تستخدم أیضا لمرض الجذام.<br />&bull; الافیدرین الذي یساعد على تضیق الأوعیة الدمویة.<br />&bull; تتراكوساكتید.<br />&bull; میثوتریكسیت المستخدم للأورام أو مشاكل الالتھابات.<br />إذا لم تكن متأكدا مما إذا كان أي مما سبق ینطبق علیك ، تحدث مع طبیبك أو الصیدلي قبل تناول دیمزون .<br />الحمل والرضاعة الطبیعیة<br />تحدثي إلى طبیبك قبل تناول ھذا الدواء إذا كنتي حاملاً ، أو تخطیطي لتصبحي حاملا أو في حال الرضاعة الطبیعیة.<br />لا توجد معلومات كافیة عن استخدام دكسامیثازون أثناء الحمل لمعرفة الآثار الجانبیة المحتملة. لھذا السبب ، لا ینصح<br />باستخدامھ أثناء الحمل إلا إذا نصح طبیبك بذلك .<br />یُفرز دكسامیثازون في حلیب الثدي. قد یؤثر على نمو طفلك أو یسبب آثارًا جانبیة أخرى. أخبري طبیبك إذا كن ت أو<br />تنوي الرضاعة الطبیعیة قبل تناول دیمزون.<br />القیادة واستخدام الآلات<br />قد تشعر بالدوار عند تناول ھذا الدواء ) انظر القسم :4 الآثار الجانبیة المحتملة ( ، وھذا قد یؤثر على قدرتك على القیادة . ان حدث ھذا،<br />لا تقود السیارة أو تستخدم أدوات أو آلات .<br />ديمزون يحتوي على سوربیتول ، و مالتیتول<br />یحتوي دیمزون على سوربیتول ومالتیتول . إذا أخبرك طبیبك بأن لدیك حساسیة تجاه بعض السكریات ، اتصل بطبیبك قبل أخذ ھذا المنتج<br />الطبي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>خذ ھذا الدواء كما أخبرك الطبیب أو الصیدلي . اسأل الطبیب أو الصیدلي إذا كنت غیر متأكد .<br />أخذ ھذا الدواء<br />&bull; یحتوي ھذا الدواء على ١٠ ملغم من دكسامیثازون في كل ٥ مل . كل ١ مل یحتوي على ٢ ملغم دكسامیثازون.<br />&bull; تناول ھذا الدواء عن طریق الفم .<br /> للإستخدام عن طریق الفم، استخدم معیار الجرعة الفمویة المرفق مع العبوة.<br /> قد یخبرك طبیبك بتخفیض كمیة الملح في نظامك الغذائي.<br /> قد یطلب منك طبیبك أن تتناول مكملات البوتاسیوم أثناء تناول ھذا الدواء. إذا كان كذلك، فسیراقب طبیبك حالتك عن كثب.<br />قیاس جرعتك باستخدام المحقنة الفموية المرفقة مع العبوة :<br />1 . افتح الزجاجة: اضغط على الغطاء وأدره عكس اتجاه عقارب الساعة )الشكل 1 ) .<br />2 . أدخل محوّ ل الحقنة في عنق الزجاجة )الشكل 2 ) .<br />3 . أدر المحقنة وضعھا في فتحة المحوّ ل )الشكل 2 ) .<br />4 . اقلب الزجاجة رأسًا على عقب )الشكل 3 ) .<br />5 . املأ المحقنة بكمیة صغیرة من المحلول عن طریق سحب المكبس لأسفل )الشكل 4 أ(. ثم ادفع المكبس لأعلى<br />لإزالة أي فقاعات محتملة )الشكل 4 ب(. أخیرًا ، اسحب المكبس لأسفل حتى علامة التدریج المقابلة للكمیة<br />بالمللیترات )مل( التي حددھا طبیبك )الشكل 4 ج( .<br />6 . اقلب الزجاجة في الاتجاه الصحیح .<br />7 . قم بإزالة المحقنة من المحوّ ل. ضع نھایة المحقنة في فمك وادفع المكبس ببطء مرة أخرى لأخذ الدواء .<br />8 . اغسل المحقنة بالماء واتركھا تجف قبل استخدامھا مرة أخرى .<br />9 . أغلق الزجاجة بالغطاء البلاستیكي.<br />Dexamethasone 10 mg/ 5 ml Oral<br />Solution<br />Module 1.3.3.2<br />Leaflet<br />Version: January 2022 Page 14<br />یمكن أیضا تناول ھذا الدواء عبر أنبوب أنفي معدي NG أو أنابیب المنظار المعویة PEG فقط. یتوفر مزید من المعلومات<br />في نشرة خصائص المنتج. اسأل طبیبك أو الصیدلي أو الممرضة للحصول على مزید من المعلومات.<br />الإستعمال باستخدام أنابیب NG أو PEG<br />.1 تأكد من أن الأنبوب نظیف قبل تناول الدواء<br />.2 اغسل الأنبوب المعوي بالماء . بإستخدام حد أدنى ٥ مللیلتر .<br />.3 إستخدم الدواء في الأنبوب بواسطة جھاز قیاس مناسب ، والذي سیقدمھ الطبیب أو الصیدلي أو الممرضة .<br />.4 اغسل الأنبوب بالماء مرة أخرى بإستخدام حد أدنى ٥ مللیلتر .<br />یستخدم فقط مع أنابیب السلیكون أو PVC أو بولي یوریثین.<br />الجرعة المعتادة للبالغین وكبار السن :<br />&bull; تأخذ ٠,٠٥ ملغم إلى ١٠ ملغم كل یوم.<br /> یمكن تقسیم الجرعة الیومیة على عدة جرعات أصغر )جرعتین أو ثلاث( تؤخذ على مدار الیوم.<br /> طبیبك سیقرر لك الجرعة المطلوبة بناء على الحالة المرضیة.<br /> طبیبك سیخفض لك الجرعة عندما تتحسن حالتك، أو قد یطلب منك أخذ دواء ستیرویدي أخرى، مثل بریدنیزولون.<br />اذا كنت تأخذ ھذا الدواء كجزء من فحوصات المستشفى:<br /> خذ ٠,٠٥ ملغم ) ٠,٢٥ مل( إلى ٢ ملغم ) ١ مل( لكل جرعة.<br /> ستأخذ ھذا الدواء لفترة قصیرة من الزمن.<br />إذا كنت تأخذ أكثر ديمزون مما يجب علیك<br />إذا تناولت ھذا الدواء أكثر مما ینبغي علیك ، تحدث إلى طبیب أو اذھب إلى مستشفى على الفور . خذ معك علبة الدواء حتى یعرف<br />الطبیب ما قمت بھ .<br />إذا كنت قد نسیت أن تأخذ ديمزون<br />&bull; إذا نسیت جرعة ، خذھا حالما تتذكرھا . ومع ذلك ، إذا كان الوقت قریباً للجرعة التالیة ، فتجاوز الجرعة الفائتة .<br /> لا تأخذ جرعة مضاعفة ) جرعتان في نفس الوقت ( للتعویض عن جرعة منسیة .<br />إذا توقفت عن أخذ ديمزون<br />&bull; قد یكون من الخطر التوقف عن تناول ھذا الدواء فجأة . إذا كنت بحاجة إلى إیقاف ھذا العلاج ، اتبع نصیحة طبیبك . قد یخبرك بخفض<br />كمیة الدواء الذي تتناولھ تدریجیًا حتى تتوقف عن تناولھ تمام ا.ً وھذا یتیح الفرصة للغدة الظریة لدیك لتستعید نشاطھا الطبیعي.<br />&bull; إذا توقفت عن تناول ھذا الدواء بسرعة كبیرة ، فقد تعاني من انخفاض في ضغط الدم ، وفي بعض الحالات قد یعود المرض .<br />&bull; قد تشعر أیضا ب &quot; أعراض الانسحاب .&quot; قد یشمل ذلك الحمى والألم في العضلات والمفاصل ، وتورم في داخل الأنف ، وفقدان<br />الوزن ، وحكة في الجلد والتھاب الملتحمة.<br />في حال كان لدیك أي تساؤلات حول استخدام ھذا الدواء، اسأل طبیبك أو الصیدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>مثل جمیع الأدویة ، یمكن أن یسبب ھذا الدواء آثار ا جانبیة ، على الرغم من عدم حصول الجمیع علیھا .<br />آثار جانبیة خطیرة : أخبر الطبیب فور ا<br />الستیرویدات بما في ذلك دكسامیثازون یمكن أن تسبب مشاكل صحیة عقلیة خطیرة . ھذه شائعة في كل من البالغین والأطفال . یمكن أن<br />تؤثر على حوالي ٥ من كل ١٠٠ شخص یتناولون أدویة مثل دكسامیثازون . وتشمل ھذه :<br />&bull; الشعور بالاكتئاب ، بما في ذلك التفكیر في الانتحار<br />&bull; الشعور بالنشاط ) الھوس ( أو السعادة ) النشوة ( أو الحالة المزاجیة التي ترتفع وتنخفض<br />&bull; الشعور بالقلق أو الانفعال ، مع وجود مشاكل في النوم ، وصعوبة في التفكیر أو الخلط وفقدان الذاكرة الخاصة بك<br />&bull; الشعور أو رؤیة أو سماع أشیاء غیر موجودة أو تصدیق أشیاء غیر حقیقیة ) أوھام .( امتلاك أفكار غریبة ومخیفة ، تغییر طریقة<br />Dexamethasone 10 mg/ 5 ml Oral<br />Solution<br />Module 1.3.3.2<br />Leaflet<br />Version: January 2022 Page 15<br />تصرفك أو الشعور بمفردك<br />&bull; الفصام یصبح أسوأ .<br />إذا لاحظت أیًا من ھذه المشاكل ، تحدث إلى طبیب على الفور .<br />إذا كان لديك رد فعل تحسسي تجاه ديمزون ، توقف عن استخدامھ وأطلب المساعدة الطبیة على الفور .<br />قد یشمل تفاعل الحساسیة ما یلي :<br />&bull; أي نوع من أنواع الطفح الجلدي أو الجلد المتقشر أو البثور أو التھاب الشفاه والفم<br />&bull; أزیز مفاجئ أو التصفیق أو ضیق في الصدر أو انھیار.<br />إذا كنت تعاني من أي من الآثار الجانبیة التالیة ، فتوقف عن تناول ديمزون وراجع طبیبك في أقرب وقت ممكن :<br />&bull; مشاكل المعدة والأمعاء : التھاب الأنبوب الغذائي ) المريء ( ، القرحة في الأنبوب الغذائي أو القناة الھضمیة التي قد تتمزق أو تنزف ،<br />والشعور بالغثیان أو المرض ) التقیؤ ( ، وجع المعدة أو انتفاخ البطن، المزید من الشھیة غیر المعتاد، الفواق، الإسھال، تمزق الأمعاء،<br />خاصة إذا كنت تعاني من مرض التھاب الأمعاء.<br />&bull; التھاب البنكرياس : قد یتسبب ذلك في ألم شدید في الظھر أو البطن .<br />&bull; مشاكل في الأملاح في الدم : مثل الكثیر من الصودیوم أو انخفاض البوتاسیوم أو الكالسیوم . قد یكون لدیك احتباس الماء .<br />&bull; مشاكل القلب والدم : قصور القلب لدى الأشخاص الذین یعانون من مشاكل في القلب أو ارتفاع ضغط الدم أو جلطات الدم ) قد تتضمن<br />علامات ھذا احمرار أو الألم أو التنمیل أو الخفقان أو الشعور بالانتفاخ أو التورم .( یمكن أن یكون ھناك أیضا ارتفاع كبیر في عدد<br />الخلایا البیضاء في جسمك . بعض أنواع فحوصات الدم سوف تظھر ھذا التأثیر علیك .<br />&bull; مشاكل العظام : ترقق العظام مع المزید من خطر الإصابة بالكسور ، وكذلك مشاكل في عظام الورك والذراع والساق ، وتمزق<br />الأوتار ، وھزال العضلات وضعف العضلات .<br />&bull; الالتھابات المتكررة : التي تزداد سوء ا في كل مرة . قد یكون ھذا علامة على أن نظام المناعة لدیك منخفض . تكرار الإصابة بالسل<br />) الدرن الرئوي ( إذا كنت قد عالجتھا من قبل . یمكن أیضا الاصابة بالقلاع .<br />&bull; مشاكل الجلد : الجروح التي تلتئم ببطء أكثر، والجلد الرقیق، بقع أرجوانیة غیر عادیة على الجلد أو كدمات واحمرار والتھاب<br />الجلد ، رد فعل أضعف لاختبارات الجلد ، علامات التمدد ، حَب الشباب ، التعرق أكثر من المعتاد ، الطفح الجلدي أو تورم<br />الأوردة الصغیرة .<br />&bull; مشاكل العین : إعتام عدسة العین ، زیادة الضغط في العین بما في ذلك الجلوكوما ، تورم داخل العین ، عدم وضوح الرؤیة ، ترقق<br />غطاء العین ، التھابات العین التي من یمكن أن تصبح أسوأ ، انتفاخ مقل العیون .<br />ویكون التكرر نادر اً : عدم وضوح الرؤیة . تكرر غیر معروف : الاضطرابات البصریة ، وفقدان البصر .<br />&bull; مشاكل الھرمونات : نمو شعر الجسم الزائد ) خاصة عند النساء ( ، زیادة الوزن، عدم انتظام الدورة الشھریة، والتغیرات في<br />مستویات البروتین والكالسیوم في الجسم ) ویمكن الكشف عنھ عن طریق فحص الدم ( ، توقف النمو في الأطفال والمراھقین وتضخم<br />وزیادة وزن الجسم والوجھ )یسمى &quot; حالة وجھ القمر .(&quot;<br />قد یؤثر دكسامیثازون على مرض السكري لدیك وقد تلاحظ أنك تبدأ في الحاجة لجرعات أعلى من الدواء الذي تتناولھ لمرض السكري .<br />حینما تستخدم دكسامیثازون قد لا یتمكن جسمك من الاستجابة بشكل طبیعي إلى الاجھاد الشدید مثل الحوادث أو الجراحة أو المرض .<br />&bull; مشاكل الجھاز العصبي : النوبات أو الصرع قد یصبح أسوأ ، الشعور بالدوار ، والصداع ، والصداع الشدید الغیر عادي مع مشاكل<br />بصریة عادة في الأطفال ) عادة بعد توقف العلاج ( ، شعور بأنك مدمن على الدواء، عدم القدرة على النوم، الشعور بالاكتئاب ، تقلبات<br />مزاجیة متطرفة .<br />&bull; الآثار الجانبية الأخرى : قد تشعر بأنك لست جید اً بصورة عامة . إذا كنت رجلاً ، یمكن أن یؤثر ھذا الدواء على كمیة الحیوانات<br />المنویة وحركتھا .<br />الإبلاغ عن الآثار الجانبیة<br />إذا كنت تعاني من أي آثار جانبیة ، تحدث إلى طبیبك المختص . یتضمن ذلك أي آثار جانبیة محتملة غیر مدرجة في ھذه النشرة . یمكنك<br />أیضا الإبلاغ عن الآثار الجانبیة مباشرة عبر نظام التقاریر الوطني . من خلال الإبلاغ عن الآثار الجانبیة ، یمكنك المساعدة في تقدیم<br />مزید من المعلومات حول سلامة ھذا الدواء .<br />المركز الوطني للتیقظ وسلامة الأدویة (NPC)<br />00966112057662 : الفاكس<br />الاتصال ب NPC على الرقم 00966112038222 ، تحویلة 2317-2356-2353-2354-2334-2340.:<br />الھاتف المجاني : 8002490000<br />البرید الإلكتروني : npc.drug@sfda.gov.sa<br />الموقع الإلكتروني : www.sfda.gov.sa/np</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>.5 كیفیة تخزين ديمزون<br />&bull; یحفظ ھذا الدواء بعید اً عن متناول الأطفال .<br />&bull; لا تستخدم بعد تاریخ انتھاء الصلاحیة المذكور على الملصق والكرتون )التاریخ : الشھر ، السنة(. یشیر تاریخ انتھاء الصلاحیة إلى آخر<br />یوم في ذلك الشھر .<br />&bull; لا تخزن في درجة حرارة أعلى من ٢٥ درجة مئویة. لا تحفظ بالثلاجة أو حجرة التجمید . یحفظ في علبتھ الأصلیة لحمایتھ من الضوء .<br />Dexamethasone 10 mg/ 5 ml Oral<br />Solution<br />Module 1.3.3.2<br />Leaflet<br />Version: January 2022 Page 16<br />&bull; دختسی م يف وضغ ن رھش دحاو نم حتف ا وبعل ة .<br />&bull; لا تستخدم دیمزون إذا لاحظت تغییر اً في مظھر الدواء أو رائحتھ . تحدث إلى الصیدلي .<br />&bull; لا تتخلص من أي أدویة عن طریق میاه الصرف الصحي أو النفایات المنزلیة . اسأل الصیدلي عن كیفیة التخلص من الأدویة التي لم<br />تعد تستخدمھا . ومن شأن ھذه التدابیر أن تساعد على حمایة البیئة .</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ما یحتویھ دیمزون<br />&bull; المادة الفعالة ھي دكسامیثازون )على ھیئة فوسفات الصودیوم(. كل ٥ مل تحتوي على ١٠ ملغم دكسامیثازون )على ھیئة فوسفات<br />الصودیوم .( و كل ١ مل تحتوي على ٢ ملغم دكسامیثازون )على ھیئة فوسفات الصودیوم .(<br />&bull; المكونات الأخرى ھي بروبیلین غلیكول (E1520) ، حمض البنزویك (E210) ، مونوھیدرات حامض الستریك (E330) ،<br />سترات الصودیوم E331) ( ، مالتیتول سائل (E965) ، سوربیتول سائل (E420) ، وماء منقى</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>ھو سائل عدیم اللون إلى أصفر باھت .<br />یأتي في قارورة زجاجیة بنیة اللون تحوي ٣٠ مل أو ١٥٠ مل من المحلول</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>شركة روزمونت الدوائیة المحدودة<br />منطقة یوركدیل الصناعیة، شارع بریثویت، لیدز، ل س 11 9 إكس إي،<br />المملكة المتحدة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            تم تعديل ھذه النشرة في يناير 2022
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Demsone 10mg/5ml Oral Solution
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each 5ml contains 10mg Dexamethasone (as dexamethasone sodium phosphate)
1ml contains 2mg Dexamethasone (as dexamethasone sodium phosphate)
Excipients with known effect:
Liquid maltitol 1375mg/5ml (275mg/ml)
Sorbitol liquid (non crystallising) 700mg/5ml (140mg/ml)
For the full list of excipients, see section 6.1
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Oral Solution
A colourless to faint yellow solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Dexamethasone is a corticosteroid. It is designed for use in certain endocrine and non-endocrine disorders, in certain cases of cerebral oedema and for diagnostic testing of adrenocortical hyperfunction.<br />Endocrine disorders:<br />Endocrine exophthalmos.<br />Non-endocrine disorders:<br />Dexamethasone may be used in the treatment of non-endocrine corticosteroid responsive conditions including:<br />Allergy and anaphylaxis: Anaphylaxis.<br />Arteritis collagenosis: Polymyalgia rheumatica, polyarteritis nodosa.<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.1<br />SPC<br />Version: January 2022 Page 2<br />Haematological disorders: Haemolytic anaemia (also auto immune), leukaemia, myeloma, idiopathic thrombocytopenic purpura in adults, reticulolymphoproliferative disorders (see also under oncological disorders).<br />Gastroenterological disorders: For treatment during the critical stage in: ulcerative colitis (rectal only); regional enteritis (Crohn&rsquo;s disease), certain forms of hepatitis.<br />Muscular disorders: Polymyositis.<br />Neurological disorders: Raised intra-cranial pressure secondary to cerebral tumours, acute exacerbations of multiple sclerosis.<br />Ocular disorders: Anterior and posterior uveitis, optic neuritis, chorioretinitis, iridocyclitis, temporal arteritis, orbital pseudotumour.<br />Renal disorders: Nephrotic syndrome<br />Pulmonary disorders: Chronic bronchial asthma, aspiration pneumonitis, chronic obstructive pulmonary disease (COPD), sarcoidosis, allergic pulmonary disease such as farmer&rsquo;s and pigeon breeder&rsquo;s lung, L&ouml;ffler&rsquo;s syndrome, cryptogenic fibrosing alveolitis.<br />Rheumatic disorders: some cases or specific forms (Felty&rsquo;s syndrome, Sj&ouml;rgen&rsquo;s syndrome) of rheumatoid arthritis, including juvenile rheumatoid arthritis, acute rheumatism, lupus erythematosus disseminatus, temporal arteritis (polymyalgia rheumatica).<br />Skin disorders: Pemphigus vulgaris, bullous pemphigoid, erythrodermas, serious forms of erythema multiforme (Stevens-Johnson syndrome), mycosis fungoides, bullous dermatitis herpetiformis.<br />Oncological Disorders: lymphatic leukaemia, especially acute forms, malignant lymphoma (Hodgkin&rsquo;s disease, non-Hodgkin&rsquo;s lymphoma), metastasized breast cancer, hypercalcaemia as a result of bone metastasis or Kahler&rsquo;s disease, Kahler&rsquo;s disease.<br />Various: intense allergic reactions; as immunosuppressant in organ transplantation; as an adjuvant in the prevention of nausea and vomiting and in the treatment of cancer with oncolytics that have a serious emetic effect.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology<br />In general, glucocorticoid dosage depends on the severity of the condition and response of the patient. Under certain circumstances, for instance in stress and changed clinical picture, extra dosage adjustments may be necessary.<br />The prescribed amount of solution should be withdrawn from the bottle using the oral dosing syringe supplied.<br />Adults<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.1<br />SPC<br />Version: January 2022 Page 3<br />The dosage should be titrated to the individual response and the nature of the disease. In order to minimise side effects, the lowest effective possible dosage should be used (see section 4.8).<br />Usually, daily oral dosages of 0.5 - 10 mg are sufficient. In some patients higher dosages may be temporarily required to control the disease. Once the disease is under control the dosage should be reduced or tapered off to the lowest suitable level under continuous monitoring and observation of the patient (see section 4.4).<br />The initial dosage should be maintained or adjusted until the patient&rsquo;s response is satisfactory. Both the dose in the evening, which is useful in alleviating morning stiffness, and the divided dosage regimen are associated with greater suppression of the hypothalamo-pituitary-adrenal axis.<br />If the initial response is favourable, the maintenance dosage should be determined by lowering the dose gradually to the lowest dose required to maintain an adequate clinical response. Chronic dosage should preferably not exceed 1.5mg dexamethasone daily.<br />If no favourable response is noted within a couple of days, glucocorticoid therapy should be discontinued.<br />Patients should be monitored for signs that dosage adjustment is required. These may arise from a change in clinical status (e.g. remission or exacerbation of the condition), individual corticosteroid responsiveness or as a result of concomitant stress (e.g. surgery, infection, trauma). During periods of stress it may be necessary to increase the dose temporarily.<br />If the drug is to be discontinued after more than a few days of treatment, it should be withdrawn gradually.<br />The following equivalents facilitate changing to dexamethasone from other glucocorticoids:<br />Milligram for milligram, dexamethasone is approximately equivalent to betamethasone, 4 to 6 times more potent than methylprednisolone and triamcinolone, 6 to 8 times more potent than prednisone and prednisolone, 25 to 30 times more potent than hydrocortisone, and about 35 times more potent than cortisone.<br />Acute, self-limiting allergic disorders or acute exacerbations of chronic allergic disorders.<br />The following dosage schedule combining parenteral and oral therapy is suggested:<br />First day: Dexamethasone sodium phosphate injection 4mg or 8mg (2ml or 4ml) intramuscularly.<br />Second day: 1mg (0.5ml) Demsone Oral Solution twice a day.<br />Third day: 1mg (0.5ml) Demsone Oral Solution twice a day.<br />Fourth day: 500micrograms (0.25ml) Demsone Oral Solution twice a day.<br />Fifth day: 500micrograms (0.25ml) Demsone Oral Solution twice a day.<br />Sixth day: 500micrograms (0.25ml) Demsone Oral Solution.<br />Seventh day: 500micrograms (0.25ml) Demsone Oral Solution.<br />Eighth day: Re-assessment.<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.1<br />SPC<br />Version: January 2022 Page 4<br />This schedule is designed to ensure adequate therapy during acute episodes whilst minimising the risk of overdosage in chronic cases.<br />Raised intracranial pressure: Initial therapy is usually by injection. When maintenance therapy is required, this should be changed to Demsone oral solution as soon as possible. For the palliative management of patients with recurrent or inoperable brain tumours, maintenance dosage should be calculated individually. A dosage of 2mg two or three times a day may be effective. The smallest dosage necessary to control symptoms should always be used.<br />Lower strength oral formulations may facilitate the administration of lower daily doses in the initial stages of treatment.<br />Dexamethasone suppression tests:<br />1. Tests for Cushing&rsquo;s syndrome:<br />2mg (1ml) Demsone Oral Solution should be administered at 11pm. Blood samples are then taken at 8am the next morning for plasma cortisol determination.<br />If greater accuracy is required, 500 micrograms (0.25ml) Demsone Oral Solution should be administered every 6 hours for 48 hours. Blood should be drawn at 8am for plasma cortisol determination on the third morning.<br />24-hour urine collection should be employed for 17-hydroxycorticosteroid excretion determination.<br />2. Test to distinguish Cushing&rsquo;s syndrome caused by pituitary ACTH excess from the syndrome induced by other causes:<br />2mg (1ml) Demsone Oral Solution should be administered every 6 hours for 48 hours. Blood should be drawn at 8am for plasma cortisol determination on the third morning.<br />24-hour urine collection should be employed for 17-hydroxycorticosteroid excretion determination.<br />For a short dexamethasone suppression test, the use of lower strength oral formulations may facilitate the administration of lower doses.<br />Elderly<br />The elderly may be more susceptible to the side-effects of corticosteroids particularly during long-term therapy.<br />Paediatric population<br />Due to the strength of this formulation, this product is not indicated for paediatric use.<br />Method of administration<br />For oral use.<br />Suitable for administration via nasogastric (NG) or percutaneous endoscopic gastrostomy (PEG) tubes only. For further information see section 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                − Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
− Systemic infection unless specific anti-infective therapy is employed.
− Systemic fungal infections.
− Stomach ulcer or duodenal ulcer
− Infection with tropical worms
Avoid live vaccines in patients receiving immuno suppressive doses (serum antibody response diminished).
In general no contraindications apply in conditions where the use of glucocorticoids may be life saving.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>A patient information leaflet should be supplied with this product.<br />Undesirable effects may be minimised by using the lowest effective dose for the minimum period, and by administering the daily requirement as a single morning dose or whenever possible as a single morning dose on alternative days. Frequent patient review is required to appropriately titrate the dose against disease activity. When reduction in dosage is possible, the reduction should be gradual (Refer to &lsquo;Posology and Administration&rsquo;).<br />Anti-inflammatory/Immunosuppressive effects/Infection<br />Corticosteroids may exacerbate systemic fungal infections and should not be used unless they are needed to control drug reactions due to amphotericin. There have also been reports in which concomitant use of amphotericin and hydrocortisone was followed by cardiac enlargement and heart failure.<br />If inactivated viral or bacterial vaccines are administered to individuals receiving immunosuppressive doses of corticosteroids, the expected serum antibody response may not be obtained.<br />Suppression of the inflammatory response and immune function increases the susceptibility to infections and their severity. The clinical presentation may often be atypical, and serious infections such as septicaemia and tuberculosis may be masked and may reach an advanced stage before being recognised.<br />Appropriate anti-microbial therapy should accompany glucocorticoid therapy when necessary e.g. in tuberculosis and viral and fungal infections of the eye. There may be decreased resistance and inability to localise infection in patients on corticosteroids.<br />Chickenpox is of particular concern since this normally minor illness may be fatal in immunosuppressed patients. Patients (or parents of children) without a definite history of chickenpox should be advised to avoid close personal contact with chickenpox or herpes zoster and if exposed they should seek urgent medical attention. Passive immunisation with varicella zoster immunoglobulin (VZIG) is needed by exposed non-immune patients who are receiving systemic corticosteroids or who have used them within the previous 3 months; this should be given within 10 days of exposure to chickenpox. If a diagnosis of chickenpox is confirmed, the illness warrants specialist care and urgent treatment. Corticosteroids should not be stopped and the dose may need to be increased.<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.1<br />SPC<br />Version: January 2022 Page 6<br />Measles can have a more serious or even fatal course in immunosuppressed patients. In such children or adults particular care should be taken to avoid exposure to measles. If exposed, prophylaxis with intramuscular pooled immunoglobulin (IG) may be indicated. Exposed patients should be advised to seek medical advice without delay.<br />Corticosteroids may activate latent amoebiasis or strongyloidiasis or exacerbate active disease. Latent disease may be activated or there may be an exacerbation of intercurrent infections due to pathogens, including those caused by Amoeba, Candida, Cryptococcus, Mycobacterium, Nocardia, Pneumocystis or Toxoplasma. It is recommended that these are ruled out before initiating corticosteroid therapy particularly in those patients who have spent time in the tropics or those with unexplained diarrhoea.<br />A report shows that the use of corticosteroids in cerebral malaria is associated with a prolonged coma and an increased incidence of pneumonia and gastro-intestinal bleeding and therefore corticosteroids should not be used in cerebral malaria.<br />Eye disorders<br />Prolonged use of corticosteroids may produce subcapsular cataracts, glaucoma with possible damage to the optic nerves, and may enhance the establishment of secondary ocular infections due to fungi or viruses. Particular care is needed when treating patients with glaucoma (or family history of glaucoma) as well as when treating patients with ocular herpes simplex, because of possible corneal perforation.<br />Electrolyte disturbances<br />Average and large doses of hydrocortisone or cortisone can cause elevation of blood pressure, retention of salt and water, and increased excretion of potassium, but these effects are less likely to occur with synthetic derivatives, except when used in large doses. Dietary salt restriction and potassium supplementation may be necessary with corticosteroid therapy. All corticosteroids increase calcium excretion.<br />Particular care is needed when treating patients with renal impairment, hypertention and congestive heart failure.<br />Adrenal Suppression<br />Adrenal cortical atrophy develops during prolonged therapy and may persist for years after stopping treatment. Withdrawal of corticosteroids after prolonged therapy must therefore always be gradual to avoid acute adrenal insufficiency, being tapered off over weeks or months according to the dose and duration of treatment. In patients who have received more than physiological doses of systemic corticosteroids (approximately 1 mg dexamethasone) for greater than 3 weeks, withdrawal should not be abrupt.<br />How dose reduction should be carried out depends largely on whether the disease is likely to relapse as the dose of systemic corticosteroids is reduced. Clinical assessment of disease activity may be needed during withdrawal. If the disease is unlikely to relapse on withdrawal of systemic corticosteroids but there is uncertainty about HPA suppression, the dose of systemic corticosteroid may be reduced rapidly to physiological doses. Once a daily dose of 1mg dexamethasone is reached, dose reduction should be slower to allow the HPA-axis to recover.<br />Abrupt withdrawal of systemic corticosteroid treatment, which has continued up to 3 weeks, is appropriate if it is considered that the disease is unlikely to relapse.<br />Abrupt withdrawal of doses of up to 6mg daily of dexamethasone for 3 weeks is unlikely to lead to clinically relevant HPA-axis suppression in the majority of patients.<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.1<br />SPC<br />Version: January 2022 Page 7<br />In the following patient groups, gradual withdrawal of systemic corticosteroid therapy should be considered even after courses lasting 3 weeks or less:<br />&bull; Patients who have had repeated courses of systemic corticosteroids, particularly if taken for greater than 3 weeks.<br />&bull; When a short course has been prescribed within one year of cessation of long-term therapy (months or years).<br />&bull; Patients who may have reasons for adrenocortical insufficiency other than exogenous corticosteroid therapy.<br />&bull; Patients receiving doses of systemic corticosteroid greater than 6mg daily of dexamethasone.<br />&bull; Patients repeatedly taking doses in the evening.<br />Intercurrent illness and stress<br />During prolonged therapy any intercurrent illness, trauma or surgical procedure will require a temporary increase in dosage; if corticosteroids have been stopped following prolonged therapy they may need to be temporarily re-introduced.<br />Patients under stress may require increased doses of corticosteroids prior, during and after the period of stressful situation.<br />Withdrawal symptoms<br />Stopping corticosteroids after prolonged therapy may cause withdrawal symptoms including fever, myalgia, arthralgia and malaise. This may occur in patients even without evidence of adrenal insufficiency.<br />General<br />In addition to the information given under the other headings, particular care is required when considering the use of systemic corticosteroids in patients with the following conditions and frequent patient monitoring is necessary:<br />&minus; diabetes mellitus (or a family history of diabetes)<br />&minus; osteoporosis (especially post-menopausal females)<br />&minus; hypertension or congestive heart failure<br />&minus; existing or previous history of severe affective disorders (especially previous steroid psychosis)<br />&minus; history of tuberculosis<br />&minus; glaucoma (or a family history of glaucoma)<br />&minus; previous corticosteroid-induced myopathy<br />&minus; myasthenia gravis<br />&minus; non-specific ulcerative colitis, diverticulitis or fresh intestinal anastomosis<br />&minus; peptic ulceration<br />&minus; liver failure<br />&minus; epilepsy<br />&minus; renal insufficiency<br />&minus; hypothyroidism<br />&minus; migraine<br />&minus; history of allergy to corticosteroids<br />&minus; herpes simplex<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.1<br />SPC<br />Version: January 2022 Page 8<br />There is an enhanced effect of corticosteroids in patients with hypothyroidism and in those with cirrhosis.<br />Fat embolism has been reported as a possible complication of hypercortisonism.<br />Large doses of corticosteroids may mask the symptoms of gastro-intestinal perforation.<br />Reports in the literature suggest an apparent association between use of corticosteroids and left-ventricular free-wall rupture after a recent myocardial infarction; therefore, corticosteroids should be used with great caution in these patients.<br />In rare cases, decrease or withdrawal of orally administered corticosteroids could reveal underlying disease that is accompanied by eosinophilia (e.g. Churg Strauss Syndrome) in patients with asthma.<br />The results of a randomised, placebo-controlled study suggest an increase in mortality if methylprednisolone therapy starts more than two weeks after the onset of Acute Respiratory Distress Syndrome (ARDS). Therefore, treatment of ARDS with corticosteroids should be initiated within the first two weeks of onset of ARDS.<br />Hypersensitivity<br />Rare cases of anaphylactoid or hypersensitivity reactions such as glottis oedema, urticaria and bronchospasm have been reported especially with parenteral administration of corticosteroids and in patients with a history of allergy. Prophylactic measures should be taken especially if the patient has a history of allergic reactions to medicines.<br />If such an anaphylactoid reaction occurs, the following measures are recommended: immediate slow intravenous injection of 0.1-0.5ml of adrenaline (solution of 1:1000: 0.1-0.5mg adrenaline dependent on body weight), intravenous administration of aminophylline and artificial respiration if necessary.<br />Psychiatric reactions<br />Patients and/or carers should be warned that potentially severe psychiatric adverse reactions may occur with systemic steroids (see section 4.8). Symptoms typically emerge within a few days or weeks of starting the treatment. Risks may be higher with high doses/systemic exposure (see also section 4.5 for pharmacokinetic interactions that can increase the risk of side effects), although dose levels do not allow prediction of the onset, type severity or duration of reactions. Most reactions recover after either dose reduction or withdrawal, although specific treatment may be necessary. Patients/carers should be encouraged to seek medical advice if worrying psychological symptoms develop, especially if depressed mood or suicidal ideation is suspected. Patients/carers should also be alert to possible psychiatric disturbances that may occur either during or immediately after dose tapering/withdrawal of systemic steroids, although such reactions have been reported infrequently.<br />Particular care is required when considering the use of systemic corticosteroids in patients with existing or previous history of severe affective disorders in themselves or in their first degree relatives. These would include depressive or manic-depressive illness and previous steroid pyschosis.<br />Visual disturbance<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.1<br />SPC<br />Version: January 2022 Page 9<br />Visual disturbance may be reported with systemic and topical corticosteroid use. If a patient presents with symptoms such as blurred vision or other visual disturbances, the patient should be considered for referral to an ophthalmologist for evaluation of possible causes which may include cataract, glaucoma or rare diseases such as central serous chorioretinopathy (CSCR) which have been reported after use of systemic and topical corticosteroids.<br />Use in Children and Adolescents<br />This product is not indicated for use in children however corticosteroids can cause dose-related growth retardation in infancy, childhood and adolescence, which may be irreversible. On prolonged administration glucocorticoids may accelerate epiphyseal closure.<br />Treatment should be limited to the minimum dose for the shortest period.<br />Children and adolescents on prolonged therapy should be carefully monitored<br />Preterm neonates:<br />Available evidence suggests long-term neurodevelopmental adverse events after early treatment (&lt;96 hours) of premature infants with chronic lung disease at starting doses of 0.25mg/kg twice daily.<br />Use in the Elderly<br />The common adverse effects of systemic corticosteroids may be associated with more serious consequences in old age, especially osteoporosis, hypertension, hypokalaemia, diabetes, susceptibility to infection and thinning of the skin. Close clinical supervision is required to avoid life-threatening reactions.<br />In post marketing experience tumour lysis syndrome (TLS) has been reported in patients with haematological malignancies following the use of dexamethasone alone or in combination with other chemotherapeutic agents. Patient at high risk of TLS, such as patients with high proliferative rate, high tumour burden, and high sensitivity to cytotoxic agents, should be monitored closely and appropriate precaution taken.<br />Ingredients in the formulation<br />The product contains liquid maltitol and sorbitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Effects of other medicinal products on dexamethasone:<br />Dexamethasone is metabolized via cytochrome P450 3A4 (CYP3A4). Concomitant administration of dexamethasone with inducers of CYP3A4, such as phenytoin, barbiturates (e.g. primidone and phenobarbital), ephedrine, rifabutin, carbamazepine and rifampicin may lead to decreased plasma concentrations of dexamethasone and the dose may need to be increased.<br />Dexamethasone reduces the plasma concentration of the antiviral drugs indinavir and saquinavir.<br />Patients taking methotrexate and dexamethasone have an increased risk of haematological toxicity.<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.1<br />SPC<br />Version: January 2022 Page 10<br />Concomitant administration of inhibitors of CYP3A4 such as ketoconazole, ritonavir and erythromycin may lead to increased plasma concentrations of dexamethasone.<br />These interactions may also interfere with dexamethasone suppression tests, which therefore should be interpreted with caution during administration of substances that affect the metabolism of dexamethasone.<br />Ketoconazole may increase plasma concentrations of dexamethasone by inhibition of CYP3A4, but may also suppress corticosteroid synthesis in the adrenal and thereby cause adrenal insufficiency at withdrawal of corticosteroid treatment.<br />Co-treatment with CYP3A inhibitors, including cobicistat-containing products, is expected to increase the risk of systemic side-effects. The combination should be avoided unless the benefit outweighs the increased risk of systemic corticosteroid side-effects, in which case patients should be monitored for systemic corticosteroid side-effects.<br />Ephedrine may increase the metabolic clearance of corticosteroids, resulting in decreased plasma levels. An increase of the corticosteroid dose might be necessary.<br />False-negative results in the dexamethasone suppression test inpatients being treated with indometacin have been reported.<br />Antibiotics: Macrolide antibiotics have been reported to cause a significant decrease in corticosteroid clearance<br />Anticholinesterases: Concomitant use of anticholinesterase agents and corticosteroids may produce severe weakness in patients with myasthenia gravis. If possible, anticholinesterase agents should be withdrawn at least 24 hours before initiating corticosteroid therapy.<br />Colestyramine: Colestyramine may decrease the absorption of dexamethasone.<br />Estrogens, including oral contraceptives: Estrogens may decrease the hepatic metabolism of certain corticosteroids, thereby increasing their effect<br />Aminoglutethimide: Decrease of dexamethasone efficacy, due to its metabolism increase. An adjustment of dexamethasone dosage may be required.<br />Gastrointestinal topicals, antacids, charcoal: A decrease in digestive absorption of glucocorticoids have been reported with prednisolone and dexamethasone. Therefore, glucocorticoids should be taken separately from gastrointestinal topicals, antacids or charcoal, with an interval between treatment of at least two hours.<br />Effects of dexamethasone on other medicinal products<br />Dexamethasone is a moderate inducer of CYP3A4. Concomitant administration of dexamethasone with substances that are metabolised via CYP3A4 could lead to increased clearance and decreased plasma concentrations of these substances.<br />The renal clearance of salicylates is increased by corticosteroids and therefore, salicylate dosage should be reduced along with steroidal withdrawal which may result in salicylate intoxication.<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.1<br />SPC<br />Version: January 2022 Page 11<br />The desired effects of hypoglycaemic agents (including insulin), anti-hypertensives and diuretics are antagonised by corticosteroids.<br />The hypokalaemic effects of acetazolamide, loop diuretics, thiazide diuretics, amphotericin B injection, potassium depleting agents, corticosteroids (gluco-mineralo), tetracosactide and carbenoxolone are enhanced. Hypokalaemia predisposes to cardiac arrhythmia especially &ldquo;torsade de pointes&rdquo; and increase the toxicity of cardiac glycosides. Hypokalemia should be corrected before corticosteroid treatment initiation. In addition, there have been cases reported in which concomitant use of amphotericin B and hydrocortisone was followed by cardiac enlargement and congestive heart failure.<br />The efficacy of coumarin anticoagulants may be enhanced by concurrent corticosteroid therapy and close monitoring of the INR or prothrombin time is required to avoid spontaneous bleeding.<br />Sultopride has been linked to ventricular arrhythmias, especially torsade de pointes. This combination is not recommended.<br />Patients taking NSAID&#39;s should be monitored since the incidence and/or severity of gastro-ulceration may increase. Aspirin should also be used cautiously in conjunction with corticosteroids in hypoprothrombinaemia.<br />Antitubercular drugs: Serum concentrations of isoniazid may be decreased.<br />Ciclosporin: Increased activity of both ciclosporin and corticosteroids may occur when the two are used concurrently. Convulsions have been reported with this concurrent use.<br />Thalidomide: Co-administration with thalidomide should be employed cautiously, as toxic epidermal necrolysis has been reported with concomitant use.<br />Corticosteroids may affect the nitrobuletetrazolium test for bacterial infection and produce false-negative results.<br />Vaccines attenuated live<br />Risk of fatal systemic disease<br />Praziquantel:<br />Decrease in praziquantel plasmatic concentrations, with a risk of treatment failure, due to its hepatic metabolism increased by dexamethasone.<br />Oral anticoagulants:<br />Possible impact of corticosteroid therapy on the metabolism of oral anticoagulants and on clotting factors. At high doses or with treatment for more than 10 days, there is a risk of bleeding specific to corticosteroid therapy (gastrointestinal mucosa, vascular fragility). Patients taking corticosteroids associated with oral anticoagulants should be closely monitored (biological investigations on 8th day, then every 2 weeks during treatment and after treatment discontinuation).<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.1<br />SPC<br />Version: January 2022 Page 12<br />Insulin, sulfonylureas, metformin:<br />Increase in blood glucose, with sometimes diabetic ketosis, since corticosteroids impair carbohydrate tolerance. Therefore, blood and urine self-monitoring should be reinforced by the patient, in particular at the start of treatment<br />Isoniazid:<br />A decrease in plasma isoniazid levels have been reported with prednisolone. The suggested mechanism is an increase in hepatic metabolism of isoniazid and a decrease in the hepatic metabolism of isoniazid and a decrease in the hepatic metabolism of glucocorticoids. Patients taking isoniazid should be closely monitored.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy<br />Since adequate human reproduction studies have not been performed with corticosteroids, dexamethasone should not be used during pregnancy for maternal indications, unless it is clearly necessary. The lowest effective dose needed to maintain adequate disease control should be used.<br />Infants born of mothers who have received substantial doses of corticosteroids during pregnancy should be carefully observed for signs of hypoadrenalism.<br />Patients with pre-eclampsia or fluid retention require close monitoring.<br />Placental transfer in considerable: foetal serum concentrations are similar to maternal concentrations.<br />When corticosteroids are essential however, patients with normal pregnancies may be treated as though they were in the non-gravid state.<br />Administration of corticosteroids to pregnant animals can cause abnormalities of foetal development including cleft palate, intrauterine growth retardation and affects on brain growth and development. There is no evidence that corticosteroids result in an increased incidence of congenital abnormalities, such as cleft palate/lip in man. See also section 5.3 of the SmPC.<br />Breast-feeding<br />Corticosteroids are excreted in small amounts in breast milk and may suppress growth, interfere with endogenous corticosteroid production or cause other unwanted effects. A decision on whether to continue/discontinue breast feeding or to continue/discontinue therapy with dexamethasone should be made taking into account the benefit of breast feeding to the child and the benefit of dexamethasone therapy to the woman.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are some side effects associated with this product that may affect some patients&rsquo; ability to drive or operate machinery (see section 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The incidence of predictable undesirable effects, including hypothalamic-pituitary-adrenal suppression correlates with the relative potency of the drug, dosage, timing of administration and the duration of treatment (see section 4.4).<br />The following side effects have been reported; there frequency is unknown.<br />System Organ Class<br />Infections and infestations<br />Increased susceptibility and severity of infections with suppression of clinical symptoms and signs, opportunistic infections, recurrence of dormant tuberculosis. Decreased resistance to infection.<br />Blood and lymphatic system disorders<br />Leucocytosis<br />Immune system disorders<br />Hypersensitivity including anaphylaxis has been reported. Decreased responsiveness to vaccination and skin tests.<br />Endocrine disorders<br />Menstrual irregularities and amenorrhoea, suppression of the hypothalamic-pituitary-adrenal axis, premature epiphyseal closure, development of Cushingoid state, hirsutism, secondary adrenocortical and pituitary unresponsiveness (particularly in times of stress, as in trauma, surgery or illness). Negative protein and calcium balance.<br />Metabolism and nutrition disorders<br />Sodium and water retention, potassium loss, hypokalaemic alkalosis, increased calcium excretion. Increased appetite. Impaired carbohydrate tolerance with increased requirement for anti-diabetic therapy.<br />Nervous system disorders<br />Convulsions and aggravation of epilepsy, vertigo, headache, increased intra-cranial pressure with papilloedema in children (Pseudotumour cerebri), usually after treatment withdrawal, psychological dependence, depression, insomnia, aggravation of schizophrenia and psychic disturbances ranging from euphoria to frank psychotic manifestations.<br />A wide range of psychiatric reactions including affective disorders (such as irritable, euphoric, depressed and labile mood and suicidal thoughts), psychotic reactions (including mania, delusions, hallucinations and aggravation of schizophrenia), behavioural disturbances, irritability, anxiety, sleep disturbances and cognitive dysfunction including confusion and amnesia have been reported. Reactions are common and may occur in both adults and children. In adults, the frequency of severe reactions<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.1<br />SPC<br />Version: January 2022 Page 14<br />has been estimated to be 5-6%. Psychological effects have been reported on withdrawal of corticosteroids; the frequency is unknown.<br />Eye disorders<br />Posterior subcapsular cataracts, increased intra-ocular pressure, glaucoma, papilloedema, corneal or scleral thinning, exacerbation of ophthalmic viral or fungal diseases, exopthalmos.<br />Frequency rare: Vision blurred (see also section 4.4)<br />Frequency not known: Chorioretinopathy<br />Cardiac disorders<br />Myocardial rupture following recent myocardial infarction. Congestive heart failure in susceptible patients.<br />Vascular disorders<br />Thromboembolism, hypertension<br />Gastrointestinal disorders<br />Dyspepsia, peptic ulceration with perforation and haemorrhage, acute pancreatitis, candidiasis. Abdominal distension and vomiting. Oesophageal ulceration. Perforation of the small and large bowel particularly in patients with inflammatory bowel disease. Nausea, hiccups.<br />Skin and subcutaneous tissue disorders<br />Impaired wound healing, thin fragile skin, petechiae and ecchymoses, erythema, striae, telangiectasia, acne, increased sweating, suppressed reaction to skin tests, other cutaneous reactions such as allergic dermatitis, urticaria, angioneurotic oedema, thinning scalp hair<br />Musculoskeletal and connective tissue disorders<br />Osteoporosis, vertebral and long bone fractures, avascular necrosis, tendon rupture. Proximal myopathy. Muscle weakness, aseptic necrosis of femoral and humeral heads, loss of muscle mass. Growth suppression in infants, children and adolescents.<br />General disorders and administration site conditions<br />Malaise, abnormal fat deposits.<br />Injury and poisoning<br />Bruising.<br />Investigations<br />Increased or decreased motility and number of spermatozoa, weight gain.<br />Withdrawal symptoms and signs<br />Too rapid a reduction of corticosteroid dosage following prolonged treatment can lead to acute adrenal insufficiency, hypotension and death (see section 4.4).<br />A &#39;withdrawal syndrome&#39; may also occur including, fever, myalgia, arthralgia, rhinitis, conjunctivitis, painful itchy skin nodules and loss of weight.<br />Reporting of suspected adverse reactions<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.1<br />SPC<br />Version: January 2022 Page 15<br />Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professional are asked to report any suspected adverse reactions via the national reporting system:<br />&minus; The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222, Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Reports of acute toxicity and/or deaths following overdosage with glucocorticoids are rare. No antidote is available. Treatment is probably not indicated for reactions due to chronic poisoning unless the patient has a condition that would render him unusually susceptible to ill effects from corticosteroids. In this case, the stomach should be emptied and symptomatic treatment should be instituted as necessary. Anaphylactic and hypersensitivity reactions may be treated with epinephrine (adrenaline), positive-pressure artificial respiration and aminophylline. The patient should be kept warm and quiet. The biological half life of dexamethasone in plasma is about 190 minutes</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic Group: Corticosteroid, ATC Code: H02A B02<br />Dexamethasone is a synthetic glucocorticoid whose anti-inflammatory potency is 7 times greater than prednisolone. Like other glucocorticoids, dexamethasone also has anti-allergic, antipyretic and immunosuppressive properties.<br />Dexamethasone has practically no water and salt-retaining properties and is, therefore, particularly suitable for the use in patients with cardiac failure or hypertension. Because of its long biological half-life (36-54 hours), dexamethasone is especially suitable in conditions where continuous glucocorticoid action is desired.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Corticosteroids, are, in general, readily absorbed from the gastro-intestinal tract. They are also well absorbed from sites of local application. Water-soluble forms of corticosteroids are given by intravenous injection for a rapid response; more prolonged effects are achieved using lipid-soluble forms of corticosteroids by intramuscular injection.<br />Dexamethasone 10mg/5ml Oral Solution Module 1.3.1<br />SPC<br />Version: January 2022 Page 16<br />Corticosteroids are rapidly distributed to all body tissues. They cross the placenta and may be excreted in small amounts in breast milk.<br />Most corticosteroids in the circulation are extensively bound to plasma proteins, mainly to globulin and less so to albumin. The corticosteroid-binding globulin has high affinity but low binding capacity, while the albumin has low affinity but large binding capacity. The synthetic corticosteroids are less extensively protein bound than hydrocortisone (cortisol). They also tend to have longer half-lives.<br />Corticosteroids are metabolised mainly in the liver but also in the kidney, and are excreted in the urine. The slower metabolism of the synthetic corticosteroids with their lower protein-binding affinity may account for their increased potency compared with the natural corticosteroids.<br />10mg/5ml Oral Solution<br />A bioequivalence study was performed on Demsone 10mg/5ml Oral Solution against the brand leaders 2mg tables. Data is provided below to show that the two products are bioequivalent and interchangeable mg for mg.<br />Demsone 10mg/5ml Oral Solution vs. Dexamethasone Tablets BP 2mg<br />AUC0-t<br />AUC0-inf<br />Cmax<br />Ratio<br />98.45%<br />97.93%<br />101.86%<br />90% Geometric C.I.<br />89.64% to 108.13%<br />88.37% to 108.52%<br />90.38% to 114.79%<br />Intra-Subject CV<br />12.84%<br />14.08%<br />16.41%</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In animal studies, cleft palate was observed in rats, mice, hamsters, rabbits, dogs and primates; not in horses and sheep. In some cases these divergences were combined with defects of the central nervous system and of the heart. In primates, effects in the brain were seen after exposure. Moreover, inter-uterine growth can be delayed. All these effects were seen at high doses.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Propylene Glycol (E1250)<br />Benzoic Acid (E210)<br />Citric Acid Monohydrate (E330)<br />Sodium Citrate (E331)<br />Liquid Maltitol (E965)<br />Sorbitol liquid (non crystallising) (E420)<br />Purified Water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened: 17 months
Once opened: use within 1 month. Discard any unused solution
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25&deg;C. Do not refrigerate or freeze. Store in the original package in order to protect from light.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Bottle: Amber (Type III glass)<br />Closure: HDPE, EPE wadded, child resistant closure<br />Dosing Device: Polypropylene body, purple HDPE plunger with a capacity of 5ml and dosage graduation at every 0.25ml.<br />Bottle Adaptor: Low density polyethylene<br />Pack size: 30ml or 150ml<br />Not all pack sizes may be marketed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not use the product if solid particles are observed inside the solution.<br />Any unused medicinal product or waste material should be disposed of in accordance with local requirements.<br />For oral administration<br />The prescribed amount of solution should be withdrawn from the bottle using the oral dosing syringe supplied.<br />Instructions for administration via nasogastric (NG) or percutaneous endoscopic gastrostomy (PEG) tubes</p><p>Demsone Oral Solution is suitable for use with the following type of NG and PEG tubes:<br />Material<br />External Bore Size (Fr Unit)<br />Internal Diameter (mm)<br />Maximum Length (cm)<br />Silicone<br />4<br />0.80<br />125<br />6<br />1.00<br />125<br />10<br />2.00<br />125<br />PVC<br />4<br />0.80<br />125<br />8<br />1.50<br />125<br />12<br />2.50<br />125<br />Polyurethane<br />4<br />0.80<br />125<br />8<br />1.50<br />125<br />12<br />2.60<br />125<br />18<br />4.00<br />125<br />Ensure that the enteral feeding tube is free from obstruction before administration.<br />1. Flush the enteral tube with water, a minimum flush volume of 5mL of water is required.<br />2. Administer the required dose of Demsone Oral Solution with a suitable measuring device. The oral syringe included in the pack is only for patients who are able to swallow the medicine. HCPs must use another suitable device.<br />3. Flush the enteral tube with water again using a minimum volume of 5mL of water.<br />This product should be administered with Silicone, PVC, polyurethane NG or PEG tubes only.<br />Healthcare professional should be aware that with air flushing procedure there is a risk of under dosing (up to 50%). It is therefore recommended that only water flush is used.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Rosemont Pharmaceuticals Ltd
Rosemont House
Yorkdale Industrial Park
Braithwaite Street
Leeds
LS11 9XE
UK
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                January 2022
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>